Fosun Pharmaceutical

Shanghai, China Founded: 1994 • Age: 32 yrs
Research, development, production, and sale of pharmaceuticals are provided.
Annual revenue $5.6B Latest available
Total funding - Funding intelligence
Employees 40560 Tracked headcount
Investors - Known backers
Products 2 Services tracked
Competitors - Brand Intelligence

About Fosun Pharmaceutical

Fosun Pharmaceutical is a company based in Shanghai (China) founded in 1994. The company has 40,560 employees as of December 31, 2024. Fosun Pharmaceutical has completed 3 acquisitions, including Antejin Biotech, Breas Medical and Yiyanyun Medical Technology. Fosun Pharmaceutical offers products and services including Pharmaceuticals and Medical Devices.

  • Headquarter Shanghai, China
  • Employees 40560 as on 31 Dec, 2024
  • Stage Public
  • Sectors
    Healthcare
  • Email
    Locked
  • Phone
    Locked
  • Website
    Locked
  • Social
    Locked
  • Legal Name Shanghai Fosun Pharmaceutical (Group) Co., Ltd. Class A
Operational Areas
Healthcare → Pharmaceuticals & Therapeutics Unlock Sub-Sector Unlock Segment
Healthcare → Medical Devices & Diagnostics Unlock Sub-Sector Unlock Segment
Key Metrics
  • Annual Revenue
    $5.58 B (USD)
    -0.91
    as on Dec 31, 2024
  • Net Profit
    $379.48 M (USD)
    16.13
    as on Dec 31, 2024
  • EBITDA
    $791.85 M (USD)
    45.82
    as on Dec 31, 2024
  • Latest Funding Round
    Not available
  • Investors
    Not available
  • Employee Count
    40560

    as on Dec 31, 2024

  • Investments & Acquisitions
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

IPO & Listings of Fosun Pharmaceutical

Fosun Pharmaceutical is a publicly listed company on the SSE with ticker symbol 600196 in China, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.

Exchange: SSE · Ticker: 600196 · Sector: Health technology · China

Products & Services of Fosun Pharmaceutical

Fosun Pharmaceutical offers a comprehensive portfolio of products and services, including Pharmaceuticals and Medical Devices.

Product name locked
Category locked
Primary

Pharmaceuticals are developed and manufactured for various treatments, focusing on patient needs and clinical demands.

Product name locked
Category locked
Locked

Medical devices and diagnostics are produced and supplied for health services, including tools for diagnosis and treatment.

Funding Insights of Fosun Pharmaceutical

Premium access

Detailed funding history for Fosun Pharmaceutical

Round names, dates, amounts, investors, and valuation history require an active premium plan.

  • Round names and dates
  • Funding amounts
  • Participating investors
  • Valuation history

Verified entity values are shown only after access is granted.

Investments & Acquisitions by Fosun Pharmaceutical

Fosun Pharmaceutical has strategically engaged in corporate development activities, having acquired 3 companies. Notable acquisitions include Antejin Biotech, Breas Medical and Yiyanyun Medical Technology.

Investments
Premium access

Investment portfolio details for Fosun Pharmaceutical

Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.

  • Portfolio identities
  • Transaction dates
  • Round details
  • Investment values

Verified entity values are shown only after access is granted.

Acquisitions
Company Name Description Domain Location Founded Year Amount
Software solutions for pharmacy R&D management are provided.
Locked Locked 2018 Locked
Sleep therapy and home care ventilation devices
Locked Locked 1991 Locked
Bacterial vaccine development and pharmaceutical services are provided.
Locked Locked 0 Locked
Premium access

Complete acquisition details for Fosun Pharmaceutical

Transaction dates, acquired stakes, disclosed values, domains, and locations require an active premium plan.

  • Transaction dates
  • Acquired stakes
  • Disclosed values
  • Domains and locations

Verified entity values are shown only after access is granted.

Financial Statements - Fosun Pharmaceutical

Premium access

Detailed financials for Fosun Pharmaceutical

Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.

  • Historical revenue
  • Profit trends
  • Statement rows
  • Financial ratios

Verified entity values are shown only after access is granted.

Fosun Pharmaceutical Comparisons

Fosun Pharmaceutical Primary company
Description
Research, development, production, and sale of pharmaceutica...
Location
Shanghai, China
Founded Year
1994
Annual Revenue
$5.58 B (USD)
Net Profit
$379.48 M (USD)
EBITDA
$791.85 M (USD)
Employees
40,560
As of 2024
Premium access

Peer comparison for Fosun Pharmaceutical

Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.

  • Named peers
  • Headcount comparison
  • Funding comparison
  • Operating benchmarks

Verified entity values are shown only after access is granted.

+
Add Comparison
Available on Premium

Competitors of Fosun Pharmaceutical

Premium access

Detailed competitors of Fosun Pharmaceutical

Competitor domains, locations, full profiles, and operating metrics require an active premium plan.

  • Domains and locations
  • Full company profiles
  • Operating metrics
  • Competitive positioning

Verified entity values are shown only after access is granted.

Latest news on Fosun Pharmaceutical

Premium access

Complete news archive for Fosun Pharmaceutical

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Fosun Pharmaceutical

Fosun Pharmaceutical was founded in 1994.

Fosun Pharmaceutical is headquartered in Shanghai, China.

As of Dec 31, 2024, the latest employee count at Fosun Pharmaceutical is 40,560.

Annual revenue of Fosun Pharmaceutical is $5.58B as on Dec 31, 2024.

Fosun Pharmaceutical was founded in 1994 in Shanghai, China, where operations in the pharmaceutical sector are centered. Research, development, production, and sales of pharmaceuticals are conducted globally. In 2021, annual revenues of 6.03B were achieved, alongside a net profit of 0.73B. The company is headquartered in Shanghai and maintains a presence in the healthcare industry through its core activities.

Fosun Pharmaceutical offers Pharmaceuticals and Medical Devices.

Yes, Fosun Pharmaceutical is publicly traded on SSE under the ticker symbol 600196.

Fosun Pharmaceutical has made 3 acquisitions, including Antejin Biotech, Breas Medical, and Yiyanyun Medical Technology.

The ticker symbol of Fosun Pharmaceutical is 600196 on SSE.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available